Arama Sonuçları - Philippe L. L’Allier

Sonuçları Daraltın
  1. 1
    Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease

    Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease Yazar: Raed Osman, Philippe L. L’Allier, Nader Elgharib, Jean‐Claude Tardif

    Baskı/Yayın Bilgisi 2006
    Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Importance of collateral circulation in coronary heart disease

    Importance of collateral circulation in coronary heart disease Yazar: Colin Berry, Kanarath Balachandran, Philippe L. L’Allier, Jacques Lespérance, R Bonan, K. G. Oldroyd

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Revisão
    Favorilerime ekle
    Kaydedildi:
  3. 3
    Comparison of Intravascular Ultrasound and Quantitative Coronary Angiography for the Assessment of Coronary Artery Disease Progression

    Comparison of Intravascular Ultrasound and Quantitative Coronary Angiography for the Assessment of Coronary Artery Disease Progression Yazar: Colin Berry, Philippe L. L’Allier, Jean‐Claude Grégoire, Jacques Lespérance, Sylvie Lévesque, Réda Ibrahim, Jean‐Claude Tardif

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Effect of treatment with 5‐lipoxygenase inhibitor <scp>VIA</scp>‐2291 (atreleuton) on coronary plaque progression: a serial <scp>CT</scp> angiography study

    Effect of treatment with 5‐lipoxygenase inhibitor <scp>VIA</scp>‐2291 (atreleuton) on coronary plaque progression: a serial <scp>CT</scp> angiography study Yazar: Suguru Matsumoto, Réda Ibrahim, Jean C. Grégoire, Philippe L. L’Allier, Joséphine Pressacco, Jean‐Claude Tardif, Matthew J. Budoff

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  5. 5
    Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions

    Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions Yazar: Jean‐Claude Tardif, Jean Grégoire, Leonard Schwartz, Lawrence Title, Louise Laramée, François Reeves, Jacques Lespérance, Martial G. Bourassa, Philippe L. L’Allier, Mitchell Glass, Jean Lambert, Marie‐Claude Guertin

    Baskı/Yayın Bilgisi 2003
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  6. 6
    Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial

    Effects of the P‐Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT‐ACS Trial... Yazar: Barbara E. Stähli, Cathérine Gebhard, Valérie Duchatelle, Daniel Cournoyer, Thibaut Petroni, Jean‐François Tanguay, Stephen Robb, Jessica Mann, Marie‐Claude Guertin, R. Scott Wright, Philippe L. L’Allier, Jean‐Claude Tardif

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  7. 7
    Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery

    Effects of P-Selectin Antagonist Inclacumab in Patients Undergoing Coronary Artery Bypass Graft Surgery Yazar: Barbara E. Stähli, Jean‐Claude Tardif, Michel Carrier, Richard L. Gallo, Robert W. Emery, Stephen Robb, Daniel Cournoyer, Lucie Blondeau, Dominique Johnson, Jessica Mann, Jacques Lespérance, Marie‐Claude Guertin, Philippe L. L’Allier

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Carta
    Favorilerime ekle
    Kaydedildi:
  8. 8
    A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

    A Randomized Controlled, Phase 2 Trial of the Viral Serpin Serp-1 in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention Yazar: Jean‐Claude Tardif, Philippe L. L’Allier, Jean Grégoire, Réda Ibrahim, Grant McFadden, William J. Kostuk, Merril L. Knudtson, Marino Labinaz, Ron Waksman, Carl J. Pepine, Colin Macaulay, Marie‐Claude Guertin, Alexandra Lucas

    Baskı/Yayın Bilgisi 2010
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  9. 9
    Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue: The COVID-Rehab Study

    Cardiopulmonary Rehabilitation in Long-COVID-19 Patients with Persistent Breathlessness and Fatigue: The COVID-Rehab Study Yazar: Florent Besnier, Béatrice Bérubé, Jacques Malo, Christine Gagnon, Catherine‐Alexandra Grégoire, Martin Juneau, François Simard, Philippe L. L’Allier, Anil Nigam, Josep Iglésies, Thomas Vincent, Deborah Talamonti, Emma Gabrielle Dupuy, Hânieh Mohammadi, Mathieu Gayda, Louis Bherer

    Baskı/Yayın Bilgisi 2022
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  10. 10
    Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction

    Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention for Non–ST-Segment Elevation Myocardial Infarction Yazar: Jean‐Claude Tardif, Jean-François Tanguay, Scott Wright, Valérie Duchatelle, Thibaut Petroni, Jean C. Grégoire, Réda Ibrahim, Therèse Heinonen, Stephen Robb, Olivier F. Bertrand, Daniel Cournoyer, Dominique Johnson, Jessica Mann, Marie-Claude Guertin, Philippe L. L’Allier

    Baskı/Yayın Bilgisi 2013
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  11. 11
    In Vivo Validation of a Catheter-Based Near-Infrared Spectroscopy System for Detection of Lipid Core Coronary Plaques

    In Vivo Validation of a Catheter-Based Near-Infrared Spectroscopy System for Detection of Lipid Core Coronary Plaques Yazar: Sergio Waxman, Simon Dixon, Philippe L. L’Allier, Jeffrey W. Moses, John L. Petersen, Donald E. Cutlip, Jean‐Claude Tardif, Richard W. Nesto, James E. Muller, Michael J. Hendricks, Stephen T. Sum, Craig M. Gardner, James A. Goldstein, Gregg W. Stone, Mitchell W. Krucoff

    Baskı/Yayın Bilgisi 2009
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  12. 12
    Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions

    Effects of the Acyl Coenzyme A:Cholesterol Acyltransferase Inhibitor Avasimibe on Human Atherosclerotic Lesions Yazar: Jean‐Claude Tardif, Jean Grégoire, Philippe L. L’Allier, Todd J. Anderson, Olivier F. Bertrand, François Reeves, Lawrence Title, Fernándo Alfonso, Érick Schampaert, Alita Hassan, Richard McLain, Milton L. Pressler, Réda Ibrahim, Jacques Lespérance, John Blue, Therèse Heinonen, Josep Rodés‐Cabau

    Baskı/Yayın Bilgisi 2004
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  13. 13
    Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation

    Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation Yazar: Jean‐Claude Tardif, David Rhainds, Mathieu R. Brodeur, Yassamin Feroz Zada, René Fouodjio, Sylvie Provost, Marie Boulé, Sonia Alem, Jean C. Grégoire, Philippe L. L’Allier, Réda Ibrahim, Marie‐Claude Guertin, Ian Mongrain, Anders Olsson, Gregory G. Schwartz, Éric Rhéaume, Marie‐Pierre Dubé

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  14. 14
    Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance

    Arterial Effects of Canakinumab in Patients With Atherosclerosis and Type 2 Diabetes or Glucose Intolerance Yazar: Robin P. Choudhury, Jacqueline Birks, Venkatesh Mani, Luca Biasiolli, Matthew D. Robson, Philippe L. L’Allier, Marc‐Alexandre Gingras, Nadia Alie, Mary Ann McLaughlin, Craig T. Basson, Alison D. Schecter, E. C. Svensson, Yiming Zhang, Denise P. Yates, Jean‐Claude Tardif, Zahi A. Fayad

    Baskı/Yayın Bilgisi 2016
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  15. 15
    The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access

    The Benefits Conferred by Radial Access for Cardiac Catheterization Are Offset by a Paradoxical Increase in the Rate of Vascular Access Site Complications With Femoral Access Yazar: Lorenzo Azzalini, Kunle Tosin, Malorie Chabot-Blanchet, Robert Avram, Hung Q. Ly, Benoit Gaudet, Richard L. Gallo, Serge Doucet, Jean‐François Tanguay, Réda Ibrahim, Jean‐Claude Grégoire, Jacques Crépeau, Raoul Bonan, Pierre de Guise, Mohamed Nosair, Jean‐François Dorval, Gilbert Gosselin, Philippe L. L’Allier, Marie‐Claude Guertin, Anita Asgar, E. Marc Jolicœur

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  16. 16
    Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

    Low-Dose Colchicine in Patients With Type 2 Diabetes and Recent Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) Yazar: François Roubille, Nadia Bouabdallaoui, Simon Kouz, David D. Waters, Rafael Díaz, Aldo P. Maggioni, Fausto J. Pinto, Jean‐Claude Grégoire, Habib Gamra, Ghassan S. Kiwan, Colin Berry, José López‐Sendón, Wolfgang Köenig, Laurent Delorme, Meyer Elbaz, Pierre Coste, Mylène Provencher, Zohar Bassevitch, Lucie Blondeau, Philippe L. L’Allier, Marie‐Claude Guertin, Jean‐Claude Tardif

    Baskı/Yayın Bilgisi 2024
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  17. 17
    Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

    Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib Yazar: Jean‐Claude Tardif, Éric Rhéaume, Louis‐Philippe Lemieux Perreault, Jean C. Grégoire, Yassamin Feroz Zada, Géraldine Asselin, Sylvie Provost, Amina Barhdadi, David Rhainds, Philippe L. L’Allier, Réda Ibrahim, Ruchi Upmanyu, Eric J. Niesor, Renée Benghozi, Gabriela Suchánková, Fouzia Laghrissi‐Thode, Marie‐Claude Guertin, Anders Olsson, Ian Mongrain, Gregory G. Schwartz, Marie‐Pierre Dubé

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  18. 18
    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

    Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) Yazar: Nadia Bouabdallaoui, Jean‐Claude Tardif, David D. Waters, Fausto J. Pinto, Aldo P. Maggioni, Rafael Díaz, Colin Berry, Wolfgang Köenig, J. López‐Sendón, Habib Gamra, Ghassan S. Kiwan, Lucie Blondeau, Andreas Orfanos, Réda Ibrahim, Jean C. Grégoire, Marie‐Pierre Dubé, Michelle Samuel, Olivier Morel, Pascal Lim, Olivier F. Bertrand, Simon Kouz, Marie‐Claude Guertin, Philippe L. L’Allier, François Roubille

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  19. 19
    Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

    Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction Yazar: Jean‐Claude Tardif, Simon Kouz, David D. Waters, Olivier F. Bertrand, Rafael Díaz, Aldo P. Maggioni, Fausto J. Pinto, Réda Ibrahim, Habib Gamra, Ghassan S. Kiwan, Colin Berry, José López‐Sendón, Petr Ošťádal, Wolfgang Köenig, Denis Angoulvant, Jean C. Grégoire, Marc-André Lavoie, Marie‐Pierre Dubé, David Rhainds, Mylène Provencher, Lucie Blondeau, Andreas Orfanos, Philippe L. L’Allier, Marie‐Claude Guertin, François Roubille

    Baskı/Yayın Bilgisi 2019
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  20. 20
    Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

    Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT) Yazar: Michelle Samuel, Jean‐Claude Tardif, Paul Khairy, François Roubille, David D. Waters, Jean‐Claude Grégoire, Fausto J. Pinto, Aldo P. Maggioni, Rafael Díaz, Colin Berry, Wolfgang Köenig, Petr Ošťádal, J. López‐Sendón, Habib Gamra, Ghassan S. Kiwan, Marie‐Pierre Dubé, Mylène Provencher, Andreas Orfanos, Lucie Blondeau, Simon Kouz, Philippe L. L’Allier, Réda Ibrahim, Nadia Bouabdallaoui, Dominic Mitchell, Marie‐Claude Guertin, Jacques LeLorier

    Baskı/Yayın Bilgisi 2020
    Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: